In line with Singapore and Hong Kong’s Personal Data Protection Act 2012 (“PDPA”) and European Union General Data Protection Regulation (“EU GDPR”), we seek your consent to collect, use and disclose your personal information, which may include but is not limited to, name, MCR number, contact information and etc for the following purposes:
a) Virtual Scientific Symposium on Sucroferric Oxyhydroxide: A Novel Iron-Based Phosphate-Binding Agent for the Management of Hyperphosphatemia in Dialysis Patients.
We would like to assure you that Fresenius Kabi takes your personal data privacy seriously, and we are committed to upholding our responsibility to safeguard any personal data that you have entrusted to our care. Your personal data will not be disclosed to any third parties without your permission. For more information on how we process your personal data, you may write to our Data Protection Officer (“DPO”) at DPO-SG_PDPA@fresenius-kabi.com, (for Singapore Participants) or dataprotectionhk@fresenius-kabi.com, (for Hong Kong Participants) to request a copy of our Personal Data Protection Policy.